FGF21 mutants and uses thereof

Details for Australian Patent Application No. 2010246038 (hide)

Owner Amgen Inc.

Inventors Belouski, Edward John; Ellison, Murielle Marie; Hamburger, Agnes Eva; Hecht, Randy Ira; Li, Yue-Sheng; Michaels, Mark Leo; Sun, Jeonghoon; Xu, Jing

Agent Shelston IP

Pub. Number AU-A-2010246038

PCT Pub. Number WO2010/129600

Priority 61/285,118 09.12.09 US; 61/285,133 09.12.09 US; 61/175,736 05.05.09 US

Filing date 4 May 2010

Wipo publication date 11 November 2010

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

Event Publications

1 December 2011 PCT application entered the National Phase

  PCT publication WO2010/129600 Priority application(s): WO2010/129600

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010246046-Endoscopic implant system and method

2010246028-Application of electric fields to the lung as therapy for pulmonary edema